GSK to acquire US biotech group behind food allergy drug for $2.2bn
- Posted on January 20, 2026
- By Financial Times
- 4 Views
GSK to acquire US biotech group behind food allergy drug for $2.2bn
Deal values Rapt Therapeutics at $58 a share, nearly double Monday’s Nasdaq closing price
